Cabayacruz, Baby Boy .

HRN: 28-73-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2026
03/30/2026
IV
30mg
Q24
Omphalitis
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamSkin & Soft TissueProphylaxis    Compliance to guidelines: